These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1766212)

  • 1. [A new concept of the development of glucocorticoid dependence in autoimmune diseases].
    Pytskiĭ VI
    Klin Med (Mosk); 1991 Oct; 69(10):3-10. PubMed ID: 1766212
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive drugs and the lymphocytes].
    Tsubura E; Saijo N
    Saishin Igaku; 1969 Aug; 24(8):1688-94. PubMed ID: 4902063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias].
    Tishchenko LM
    Vrach Delo; 1991 Aug; (8):60-3. PubMed ID: 1949738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids in the medical management of Graves' ophthalmopathy.
    Hart RH; Perros P
    Minerva Endocrinol; 2003 Sep; 28(3):223-31. PubMed ID: 14605604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
    Slavin S
    Bone Marrow Transplant; 1993 Jul; 12(1):85-8. PubMed ID: 8104072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa; Kir'iakov VA; Sapfirova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ.
    Fan H; Morand EF
    Discov Med; 2012 Feb; 13(69):123-33. PubMed ID: 22369971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the adverse reactions to adrenal corticosteroids.
    Frauman AG
    Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
    Sun J; Lin Z; Feng J; Li Y; Shen B
    Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A method of determining the glucocorticoid-resistant fraction of the lymphocytes in the peripheral blood and lymphoid organs].
    Pytskiĭ VI; Khodakova IA; Baliakin IuV; Arutiunova EE; Egorova MV
    Patol Fiziol Eksp Ter; 1986; (5):82-5. PubMed ID: 2432454
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current trends in the study of immunosuppressive agents].
    Uteshev BS
    Farmakol Toksikol; 1981; 44(1):5-12. PubMed ID: 6455303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic principles of immunopharmacology].
    Floersheim GL
    Clin Ter; 1981 Jan; 96(1):3-10. PubMed ID: 7237947
    [No Abstract]   [Full Text] [Related]  

  • 14. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
    Trune DR; Kempton JB; Gross ND
    Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased stimulation threshold in a patient with autoimmune disease: successful management with oral prednisolone and azathioprine.
    Ferraro A; Masi AS; Mazza A; Brusin MC; Conte MR
    Europace; 2009 Apr; 11(4):527-9. PubMed ID: 19196719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune diseases and immunosuppressive therapy].
    Pinther A
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):177-81. PubMed ID: 4913085
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology evaluation: abatacept, Bristol-Myers Squibb.
    Dumont FJ
    Curr Opin Mol Ther; 2004 Jun; 6(3):318-30. PubMed ID: 15264435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
    Kirwan J; Power L
    Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.